Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	vasoactive intestinal polypeptide receptor activity	VIPR1 VIPR2	5.74e-05	3	88	2	GO:0004999
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	GHRHR VIPR1 VIPR2 ITGA11 GPR25 OR2T27 CD27 TAS1R3 OR2T7 CD44 HRH1 GPR135 GPR156 C5AR1 OR6T1 ABCA7 GPR45	7.46e-05	1353	88	17	GO:0004888
GeneOntologyMolecularFunction	G protein-coupled receptor activity	GHRHR VIPR1 VIPR2 GPR25 OR2T27 TAS1R3 OR2T7 HRH1 GPR135 GPR156 C5AR1 OR6T1 GPR45	1.27e-04	884	88	13	GO:0004930
GeneOntologyMolecularFunction	dolichyl-phosphate-mannose-protein mannosyltransferase activity	POMT2 POMT1	5.28e-04	8	88	2	GO:0004169
GeneOntologyMolecularFunction	cargo receptor activity	CD44 DMBT1 ABCA7 OLR1	5.43e-04	85	88	4	GO:0038024
GeneOntologyMolecularFunction	arachidonate omega-hydroxylase activity	CYP2U1 CYP4F11	8.44e-04	10	88	2	GO:0052869
GeneOntologyMolecularFunction	fatty acid omega-hydroxylase activity	CYP2U1 CYP4F11	8.44e-04	10	88	2	GO:0120250
GeneOntologyMolecularFunction	long-chain fatty acid omega-hydroxylase activity	CYP2U1 CYP4F11	8.44e-04	10	88	2	GO:0102033
GeneOntologyMolecularFunction	dynactin binding	SPTBN5 HTT	1.23e-03	12	88	2	GO:0034452
HumanPheno	Meningoencephalocele	POMT2 FKTN POMT1	8.00e-07	5	23	3	HP:0006888
HumanPheno	Kinked brainstem	POMT2 FKTN POMT1	1.59e-06	6	23	3	HP:0012793
HumanPheno	Reduced muscle fiber alpha dystroglycan	POMT2 FKTN POMT1	1.30e-05	11	23	3	HP:0030099
HumanPheno	Hypoglycosylation of alpha-dystroglycan	POMT2 FKTN POMT1	1.30e-05	11	23	3	HP:0030046
HumanPheno	Abnormal muscle fiber alpha dystroglycan	POMT2 FKTN POMT1	1.72e-05	12	23	3	HP:0030112
HumanPheno	Type II lissencephaly	POMT2 FKTN POMT1	4.33e-05	16	23	3	HP:0007260
HumanPheno	Agyria	POMT2 FKTN POMT1	6.28e-05	18	23	3	HP:0031882
HumanPheno	Posterior fossa cyst	POMT2 FKTN POMT1	6.28e-05	18	23	3	HP:0007291
HumanPheno	Calf muscle hypertrophy	POMT2 FKTN POPDC3 POMT1	6.34e-05	50	23	4	HP:0008981
HumanPheno	Muscle hypertrophy of the lower extremities	POMT2 FKTN POPDC3 POMT1	7.99e-05	53	23	4	HP:0008968
HumanPheno	Chorioretinal dysplasia	POMT2 FKTN POMT1	1.01e-04	21	23	3	HP:0007731
HumanPheno	Metatarsus valgus	POMT2 FKTN POMT1	1.17e-04	22	23	3	HP:0010508
HumanPheno	Cerebellar dysplasia	POMT2 FKTN POMT1	1.34e-04	23	23	3	HP:0007033
HumanPheno	Neuropathic spinal arthropathy	POMT2 EBP POMT1	1.34e-04	23	23	3	HP:0008443
HumanPheno	Peters anomaly	POMT2 FKTN POMT1	1.73e-04	25	23	3	HP:0000659
HumanPheno	Anterior segment mesencyhmal dysgenesis	POMT2 FKTN POMT1	1.73e-04	25	23	3	HP:0007696
HumanPheno	Abnormality of the tongue muscle	POMT2 POMT1	1.93e-04	5	23	2	HP:0040173
HumanPheno	Retinal dysplasia	POMT2 FKTN POMT1	1.95e-04	26	23	3	HP:0007973
HumanPheno	Abnormal circulating aldolase concentration	POMT2 FKTN POMT1	1.95e-04	26	23	3	HP:0012400
HumanPheno	Buphthalmos	POMT2 FKTN POMT1	2.19e-04	27	23	3	HP:0000557
HumanPheno	Abnormal calf musculature morphology	POMT2 FKTN POPDC3 POMT1	2.51e-04	71	23	4	HP:0001430
HumanPheno	Fusion of the cerebellar hemispheres	POMT2 POMT1	2.89e-04	6	23	2	HP:0006899
HumanPheno	Abnormal muscle fiber protein expression	POMT2 FKTN POMT1	3.66e-04	32	23	3	HP:0030089
HumanPheno	Excessive daytime somnolence	POMT2 FKTN POMT1 HTT	3.79e-04	79	23	4	HP:0001262
HumanPheno	Limb-girdle muscle atrophy	POMT2 FKTN POMT1	6.12e-04	38	23	3	HP:0003797
HumanPheno	Occipital encephalocele	POMT2 FKTN POMT1	6.12e-04	38	23	3	HP:0002085
HumanPheno	Fatty replacement of skeletal muscle	FKTN POPDC3 POMT1	6.61e-04	39	23	3	HP:0012548
HumanPheno	Unsteady gait	POMT2 FKTN EBP CYP2U1 POMT1 HTT MAPK8IP3	7.18e-04	357	23	7	HP:0002317
HumanPheno	Hypoplasia of the corpus callosum	POMT2 FKTN EBP CYP2U1 POMT1 TARS2 TRRAP MAPK8IP3	7.80e-04	478	23	8	HP:0002079
HumanPheno	Abnormal thalamic size	POMT2 POMT1	8.59e-04	10	23	2	HP:0012693
HumanPheno	Decreased thalamic volume	POMT2 POMT1	8.59e-04	10	23	2	HP:0012695
HumanPheno	Abnormally large globe	POMT2 FKTN POMT1	1.01e-03	45	23	3	HP:0001090
MousePheno	abnormal Reichert's membrane morphology	POMT2 FKTN POMT1 HTT	8.40e-07	16	67	4	MP:0003954
MousePheno	abnormal parietal endoderm morphology	POMT2 FKTN POMT1 HTT	4.76e-06	24	67	4	MP:0011187
Domain	GPCR_2_VIP_rcpt	VIPR1 VIPR2	2.14e-05	2	87	2	IPR001571
Domain	PMT_4TMC	POMT2 POMT1	2.14e-05	2	87	2	PF16192
Domain	PMT_4TMC	POMT2 POMT1	2.14e-05	2	87	2	IPR032421
Domain	PMT	POMT2 POMT1	2.14e-05	2	87	2	PF02366
Domain	Glyco_trans_39/83	POMT2 POMT1	2.14e-05	2	87	2	IPR003342
Domain	GPCR_2_VIP_rcpt_1	GHRHR VIPR1	6.42e-05	3	87	2	IPR001771
Domain	SMR-like	SMR3A SMR3B	6.42e-05	3	87	2	IPR026288
Domain	PROL5-SMR	SMR3A SMR3B	6.42e-05	3	87	2	PF15621
Domain	-	CLEC14A CD44 HAPLN4 PKD1L2 OLR1	8.99e-05	97	87	5	3.10.100.10
Domain	C-type_lectin-like/link	CLEC14A CD44 HAPLN4 PKD1L2 OLR1	9.90e-05	99	87	5	IPR016186
Domain	GlyclTrfase_39-like	POMT2 POMT1	1.28e-04	4	87	2	IPR027005
Domain	CTDL_fold	CLEC14A CD44 HAPLN4 PKD1L2 OLR1	1.43e-04	107	87	5	IPR016187
Domain	HormR	GHRHR VIPR1 VIPR2	2.08e-04	25	87	3	SM00008
Domain	HRM	GHRHR VIPR1 VIPR2	2.94e-04	28	87	3	PF02793
Domain	GPCR_2_secretin-like_CS	GHRHR VIPR1 VIPR2	5.26e-04	34	87	3	IPR017983
Domain	G_PROTEIN_RECEP_F2_1	GHRHR VIPR1 VIPR2	8.52e-04	40	87	3	PS00649
Domain	GPCR_2_extracellular_dom	GHRHR VIPR1 VIPR2	8.52e-04	40	87	3	IPR001879
Domain	G_PROTEIN_RECEP_F2_3	GHRHR VIPR1 VIPR2	8.52e-04	40	87	3	PS50227
Domain	MIR	POMT2 POMT1	9.42e-04	10	87	2	PS50919
Domain	MIR	POMT2 POMT1	9.42e-04	10	87	2	PF02815
Domain	MIR	POMT2 POMT1	9.42e-04	10	87	2	SM00472
Domain	MIR_motif	POMT2 POMT1	9.42e-04	10	87	2	IPR016093
Domain	LINK	CD44 HAPLN4	1.62e-03	13	87	2	SM00445
Domain	Link_dom	CD44 HAPLN4	1.62e-03	13	87	2	IPR000538
Domain	Xlink	CD44 HAPLN4	1.62e-03	13	87	2	PF00193
Domain	LINK_1	CD44 HAPLN4	1.62e-03	13	87	2	PS01241
Domain	LINK_2	CD44 HAPLN4	1.62e-03	13	87	2	PS50963
Domain	G_PROTEIN_RECEP_F2_2	GHRHR VIPR1 VIPR2	1.63e-03	50	87	3	PS00650
Domain	7tm_2	GHRHR VIPR1 VIPR2	1.63e-03	50	87	3	PF00002
Domain	GPCR_2_secretin-like	GHRHR VIPR1 VIPR2	2.76e-03	60	87	3	IPR000832
Domain	GPCR_2-like	GHRHR VIPR1 VIPR2	2.76e-03	60	87	3	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	GHRHR VIPR1 VIPR2	2.89e-03	61	87	3	PS50261
Domain	ConA-like_dom	PAPPA2 COL20A1 NBEAL2 SLIT1 MAMDC4	3.59e-03	219	87	5	IPR013320
Domain	GPCR_3	TAS1R3 GPR156	4.25e-03	21	87	2	IPR000337
Domain	7tm_3	TAS1R3 GPR156	4.66e-03	22	87	2	PF00003
Domain	G_PROTEIN_RECEP_F3_2	TAS1R3 GPR156	4.66e-03	22	87	2	PS00980
Domain	G_PROTEIN_RECEP_F3_3	TAS1R3 GPR156	4.66e-03	22	87	2	PS00981
Domain	G_PROTEIN_RECEP_F3_1	TAS1R3 GPR156	4.66e-03	22	87	2	PS00979
Domain	G_PROTEIN_RECEP_F3_4	TAS1R3 GPR156	4.66e-03	22	87	2	PS50259
Domain	GPCR_3_C	TAS1R3 GPR156	4.66e-03	22	87	2	IPR017978
Domain	-	TMPRSS5 DMBT1	6.00e-03	25	87	2	3.10.250.10
Domain	C_TYPE_LECTIN_1	CLEC14A PKD1L2 OLR1	6.20e-03	80	87	3	PS00615
Domain	SRCR_1	TMPRSS5 DMBT1	6.48e-03	26	87	2	PS00420
Domain	SRCR_2	TMPRSS5 DMBT1	6.48e-03	26	87	2	PS50287
Domain	SRCR-like_dom	TMPRSS5 DMBT1	6.48e-03	26	87	2	IPR017448
Domain	VWFA	ITGA11 COL20A1 VWA5B1	6.63e-03	82	87	3	PS50234
Domain	SRCR	TMPRSS5 DMBT1	6.98e-03	27	87	2	IPR001190
Domain	VWA	ITGA11 COL20A1 VWA5B1	7.09e-03	84	87	3	SM00327
Domain	CLECT	CLEC14A PKD1L2 OLR1	7.09e-03	84	87	3	SM00034
Domain	C_TYPE_LECTIN_2	CLEC14A PKD1L2 OLR1	7.32e-03	85	87	3	PS50041
Domain	C-type_lectin-like	CLEC14A PKD1L2 OLR1	7.56e-03	86	87	3	IPR001304
Domain	TRYPSIN_SER	PRSS55 TMPRSS5 C1RL	8.57e-03	90	87	3	IPR033116
Pathway	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	GHRHR VIPR1 VIPR2 PDE3B GPR25 GPR45	1.26e-04	157	70	6	M4904
Pathway	WP_GPCRS_CLASS_B_SECRETINLIKE	GHRHR VIPR1 VIPR2	2.20e-04	24	70	3	M39643
Pathway	WP_GPCRS_CLASS_B_SECRETINLIKE	GHRHR VIPR1 VIPR2	2.20e-04	24	70	3	MM15992
Pathway	KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK	POMT2 POMT1	2.41e-04	5	70	2	M47610
Pathway	WP_7OXOC_AND_7BETAHC_PATHWAYS	EBP HSD11B2 SLC27A5	3.15e-04	27	70	3	M40054
Pathway	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	GHRHR VIPR1 VIPR2	5.75e-04	33	70	3	MM15066
Pathway	REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS	GHRHR VIPR1 VIPR2	5.75e-04	33	70	3	M10322
Pathway	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS	GHRHR VIPR1 VIPR2 GPR25 GPR45	7.14e-04	143	70	5	MM15055
Pubmed	Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.	POMT2 FKTN POMT1	1.78e-07	5	92	3	17878207
Pubmed	Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.	POMT2 FKTN POMT1	3.56e-07	6	92	3	19299310
Pubmed	AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.	POMT2 FKTN POMT1	3.87e-06	12	92	3	24256719
Pubmed	Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.	VIPR1 VIPR2	6.92e-06	2	92	2	17077178
Pubmed	CD44 and CD27 delineate B-precursor stages with different recombination status and with an uneven distribution in nonmalignant and malignant hematopoiesis.	CD27 CD44	6.92e-06	2	92	2	18005092
Pubmed	Effect of positive charge in VIP 16gamma-glutamyl diamino derivatives on hVPAC1 and hVPAC2 receptor function.	VIPR1 VIPR2	6.92e-06	2	92	2	17883247
Pubmed	The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors.	VIPR1 VIPR2	6.92e-06	2	92	2	19650041
Pubmed	Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2.	POMT2 POMT1	6.92e-06	2	92	2	19880378
Pubmed	Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.	VIPR1 VIPR2	6.92e-06	2	92	2	11160313
Pubmed	Physical and functional association of human protein O-mannosyltransferases 1 and 2.	POMT2 POMT1	6.92e-06	2	92	2	16698797
Pubmed	POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study.	POMT2 POMT1	6.92e-06	2	92	2	18513969
Pubmed	POMT1 and POMT2 gene mutations result in 2 cases of alpha-dystroglycanopathy.	POMT2 POMT1	6.92e-06	2	92	2	34565739
Pubmed	Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes.	VIPR1 VIPR2	6.92e-06	2	92	2	8784257
Pubmed	Siglec-15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44.	CD44 SIGLEC15	6.92e-06	2	92	2	34328657
Pubmed	Walker-Warburg syndrome.	POMT2 POMT1	6.92e-06	2	92	2	16887026
Pubmed	Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2.	POMT2 POMT1	6.92e-06	2	92	2	28512129
Pubmed	Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity.	POMT2 POMT1	6.92e-06	2	92	2	14699049
Pubmed	CD44 and CD27 expression pattern in B cell precursor acute lymphoblastic leukemia and its clinical significance.	CD27 CD44	6.92e-06	2	92	2	23263849
Pubmed	Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis.	VIPR1 VIPR2	6.92e-06	2	92	2	21711977
Pubmed	VIP impairs acquisition of the macrophage proinflammatory polarization profile.	VIPR1 VIPR2	6.92e-06	2	92	2	27381006
Pubmed	Expression of pituitary adenylate cyclase-activating polypeptide 1 and 2 receptor mRNA in gallbladder tissue of patients with gallstone or gallbladder polyps.	VIPR1 VIPR2	6.92e-06	2	92	2	16552823
Pubmed	Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.	VIPR1 VIPR2	6.92e-06	2	92	2	21878358
Pubmed	Expression of vasoactive intestinal peptide (VIP) receptors in human uterus.	VIPR1 VIPR2	6.92e-06	2	92	2	11072126
Pubmed	Gene expression of vasoactive intestinal peptide receptors in human lung cancer.	VIPR1 VIPR2	6.92e-06	2	92	2	21769421
Pubmed	Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors.	VIPR1 VIPR2	6.92e-06	2	92	2	16934434
Pubmed	Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients.	VIPR1 VIPR2	6.92e-06	2	92	2	31089161
Pubmed	VPAC1 and VPAC2 receptor deficiencies negatively influence pregnancy outcome through distinct and overlapping modulations of immune, trophoblast and vascular functions.	VIPR1 VIPR2	6.92e-06	2	92	2	36328148
Pubmed	Different roles of the two components of human protein O-mannosyltransferase, POMT1 and POMT2.	POMT2 POMT1	6.92e-06	2	92	2	21782786
Pubmed	Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	POMT2 FKTN POMT1	1.19e-05	17	92	3	20301468
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	POMT2 ITGA11 LMF2 FKTN GUSB EBP CD44 C1RL TMEM214 POMT1 EPDR1 ABCA7 HTT	1.66e-05	1201	92	13	35696571
Pubmed	Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.	VIPR1 VIPR2	2.07e-05	3	92	2	22059987
Pubmed	Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.	VIPR1 VIPR2	2.07e-05	3	92	2	22763881
Pubmed	Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer.	VIPR1 VIPR2	2.07e-05	3	92	2	20691743
Pubmed	Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.	VIPR1 VIPR2	2.07e-05	3	92	2	26881970
Pubmed	POMT2, a key enzyme in Walker-Warburg syndrome: somatic sPOMT2, but not testis-specific tPOMT2, is crucial for mannosyltransferase activity in vivo.	POMT2 POMT1	2.07e-05	3	92	2	18490429
Pubmed	CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.	HPX CD44	2.07e-05	3	92	2	15558018
Pubmed	PAC1, VPAC1, and VPAC2 Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies.	VIPR1 VIPR2	2.07e-05	3	92	2	36430275
Pubmed	VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.	VIPR1 VIPR2	2.07e-05	3	92	2	21295288
Pubmed	POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.	POMT2 POMT1	2.07e-05	3	92	2	20816175
Pubmed	LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans.	FKTN POMT1	2.07e-05	3	92	2	27496765
Pubmed	Vasoactive intestinal peptide (VIP) receptor expression in monocyte-derived macrophages from COPD patients.	VIPR1 VIPR2	2.07e-05	3	92	2	20026142
Pubmed	Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion.	POMT2 POMT1	2.07e-05	3	92	2	24297939
Pubmed	Limb-Girdle Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	POMT2 FKTN POMT1	2.30e-05	21	92	3	20301582
Pubmed	Select cognitive deficits in vasoactive intestinal peptide deficient mice.	VIPR1 VIPR2	4.14e-05	4	92	2	18616823
Pubmed	IL-6 and PACAP receptor expression and localization after global brain ischemia in mice.	VIPR1 VIPR2	4.14e-05	4	92	2	22669509
Pubmed	Expression of the murine Pomt1 gene in both the developing brain and adult muscle tissues and its relationship with clinical aspects of Walker-Warburg syndrome.	POMT2 POMT1	4.14e-05	4	92	2	17456771
Pubmed	Variants of human CLDN9 cause mild to profound hearing loss.	MYO7A CLDN9	4.14e-05	4	92	2	34265170
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	TAOK2 GLMP GDPD5 ISLR2 ADAMTS4 TNFSF13 CD177 CLEC14A NBEAL2 PRSS55 MAMDC4	5.91e-05	985	92	11	12975309
Pubmed	Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation.	VIPR1 VIPR2	6.89e-05	5	92	2	12417650
Pubmed	PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.	VIPR1 VIPR2	6.89e-05	5	92	2	20449688
Pubmed	Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality.	POMT2 POMT1	6.89e-05	5	92	2	15383666
Pubmed	Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression.	VIPR1 VIPR2	6.89e-05	5	92	2	20150284
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	POMT2 MYO7A TAS1R3 HAPLN4 PKD1L2	8.68e-05	168	92	5	30631154
Pubmed	PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells.	VIPR1 VIPR2	1.03e-04	6	92	2	17115416
Pubmed	Gpr125 Marks Distinct Cochlear Cell Types and Is Dispensable for Cochlear Development and Hearing.	MYO7A CD44	1.03e-04	6	92	2	34395423
Pubmed	Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium.	VIPR1 VIPR2	1.03e-04	6	92	2	22700375
Pubmed	The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates.	LEFTY2 ADAMTS4	1.03e-04	6	92	2	18039650
Pubmed	Expression of dystroglycan, fukutin and POMGnT1 during mouse cerebellar development.	FKTN POMT1	1.03e-04	6	92	2	12670716
Pubmed	Physiological contribution of CD44 as a ligand for E-Selectin during inflammatory T-cell recruitment.	CD44 FUT7	1.03e-04	6	92	2	21457936
Pubmed	Growth hormone and insulin-like growth factor-I enhance beta-glucuronidase gene activation by androgen in mouse kidney.	GHRHR GUSB	1.92e-04	8	92	2	10459853
Pubmed	LMO7 deficiency reveals the significance of the cuticular plate for hearing function.	MYO7A CLDN9	1.92e-04	8	92	2	30850599
Pubmed	Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors.	GHRHR VIPR1 VIPR2 HRH1 C5AR1	1.96e-04	200	92	5	18240029
Pubmed	Shroom2, a myosin-VIIa- and actin-binding protein, directly interacts with ZO-1 at tight junctions.	MYO7A SHROOM2	2.46e-04	9	92	2	17666436
Pubmed	Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice.	CD27 HRH1	3.07e-04	10	92	2	10051620
Pubmed	Two members of the TRPP family of ion channels, Pkd1l3 and Pkd2l1, are co-expressed in a subset of taste receptor cells.	TAS1R3 PKD1L2	3.07e-04	10	92	2	16805797
Pubmed	Physical mapping of the autoimmune disease susceptibility locus, Bphs: co-localization with a cluster of genes from the TNF receptor superfamily on mouse chromosome 6.	CD27 HRH1	3.75e-04	11	92	2	10441735
Pubmed	Cochlear supporting cells require GAS2 for cytoskeletal architecture and hearing.	MYO7A CD44	3.75e-04	11	92	2	33964205
Pubmed	CDK6 kinase activity is required for thymocyte development.	CD27 CD44	3.75e-04	11	92	2	21508411
Pubmed	β-Catenin transcriptional activity is required for establishment of inner pillar cell identity during cochlear development.	MYO7A CD44	3.75e-04	11	92	2	37639482
Pubmed	alphaII-betaV spectrin bridges the plasma membrane and cortical lattice in the lateral wall of the auditory outer hair cells.	SPTBN5 MYO7A	5.30e-04	13	92	2	18796539
Pubmed	Association of genetic variants with hemorrhagic stroke in Japanese individuals.	SPTBN5 VIPR2 GPR135 FUT7	5.78e-04	143	92	4	20198315
Pubmed	A non-autonomous function of the core PCP protein VANGL2 directs peripheral axon turning in the developing cochlea.	MYO7A CD44	6.17e-04	14	92	2	29784671
Pubmed	Genetic rescue of Muenke syndrome model hearing loss reveals prolonged FGF-dependent plasticity in cochlear supporting cell fates.	MYO7A CD44	8.11e-04	16	92	2	24145799
Pubmed	Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.	PDE3B HTT	8.11e-04	16	92	2	27721240
Pubmed	Selective inhibition of heterotrimeric Gs signaling. Targeting the receptor-G protein interface using a peptide minigene encoding the Galpha(s) carboxyl terminus.	GHRHR VIPR1 VIPR2	8.62e-04	70	92	3	12036966
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	TAOK2 PDE3B LMF2 SCAMP4 TMEM214 TARS2 MTX1 PCK2 RABGGTB	8.82e-04	942	92	9	31073040
Pubmed	Intrauterine Pressures Adjusted by Reichert's Membrane Are Crucial for Early Mouse Morphogenesis.	LEFTY2 FKTN	1.03e-03	18	92	2	32433954
Pubmed	Loss of Glis3 causes dysregulation of retrotransposon silencing and germ cell demise in fetal mouse testis.	REC8 LEFTY2	1.15e-03	19	92	2	29941866
Pubmed	Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.	GUSB EPDR1	1.15e-03	19	92	2	29514215
Pubmed	Dissociation of heterotrimeric g proteins in cells.	GHRHR VIPR1 VIPR2 HRH1	1.33e-03	179	92	4	18577758
Pubmed	A series of recombinant inbred strains between the BALB/cHeA and STS/A mouse strains.	GUSB CD44	1.41e-03	21	92	2	4042679
Pubmed	EMX2-GPR156-Gαi reverses hair cell orientation in mechanosensory epithelia.	MYO7A GPR156	1.54e-03	22	92	2	34001891
Pubmed	BDNF and NT4 play interchangeable roles in gustatory development.	ISLR2 CD44	1.69e-03	23	92	2	24378336
Pubmed	Single-cell RNA-sequencing analysis of the developing mouse inner ear identifies molecular logic of auditory neuron diversification.	ISLR2 MYO7A	1.84e-03	24	92	2	35790771
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	VIPR1 PDE3B TMPRSS5 POMT1 HSD11B2 TARS2 SHROOM2 TRRAP CYP4F11 HTT MAPK8IP3	1.91e-03	1489	92	11	28611215
Pubmed	Morphogenetic lung defects of JSAP1-deficient embryos proceeds via the disruptions of the normal expressions of cytoskeletal and chaperone proteins.	LEFTY2 MAPK8IP3	2.00e-03	25	92	2	18324732
Pubmed	Chd2 Is Necessary for Neural Circuit Development and Long-Term Memory.	VIPR2 MYO7A	2.33e-03	27	92	2	30344048
Pubmed	VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.	VIPR1 VIPR2	2.33e-03	27	92	2	21737879
Pubmed	Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins.	TAOK2 VIPR1 OLR1	2.48e-03	101	92	3	23382219
Pubmed	Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo.	LEFTY2 HTT	2.50e-03	28	92	2	16109169
Pubmed	Systematic protein-protein interaction mapping for clinically relevant human GPCRs.	VIPR2 SCAMP4 HRH1 TMEM187 ABCA7 RABGGTB HTT	2.54e-03	697	92	7	28298427
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TAOK2 GDPD5 MYO7A NBEAL2 TMEM187 TRRAP ABCA7 HTT MAPK8IP3	2.63e-03	1105	92	9	35748872
GeneFamily	Vasoactive intestinal peptide receptor family	VIPR1 VIPR2	3.35e-05	3	61	2	264
GeneFamily	Dolichyl D-mannosyl phosphate dependent mannosyltransferases\|Phosphatidylinositol glycan anchor biosynthesis	POMT2 POMT1	3.97e-04	9	61	2	430
GeneFamily	G protein-coupled receptors, Class A orphans	GPR25 GPR135 GPR45	2.32e-03	78	61	3	262
Coexpression	NABA_MATRISOME	LEFTY2 PAPPA2 ADAMTS4 TNFSF13 COL20A1 CLEC14A SLIT1 HPX NTN5 HAPLN4 SEMA3G DMBT1 CTSO VWA5B1	7.35e-06	1008	89	14	MM17056
Coexpression	NABA_MATRISOME	LEFTY2 PAPPA2 ADAMTS4 TNFSF13 COL20A1 CLEC14A SLIT1 HPX NTN5 HAPLN4 SEMA3G DMBT1 CTSO VWA5B1	8.98e-06	1026	89	14	M5889
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDE3B MYO7A CD44 C1RL C5AR1 OLR1	1.14e-06	165	91	6	1dcd6b8aa192baeaa1f7bb334843edab6049b96f
ToppCell	Endothelial-Endothelial-C\|Endothelial / shred on cell class and cell subclass (v4)	DUOX1 CLEC14A TMEM44 CD44 C1RL SEMA3G	1.72e-06	177	91	6	b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VIPR1 TCAF2 PDE3B TMEM44 SEMA3G SHROOM2	3.10e-06	196	91	6	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CD177 NBEAL2 CD44 C5AR1 CYP4F11 OLR1	3.48e-06	200	91	6	fd1b6db3c62f5a205b769ba0e61433dae6285b67
ToppCell	LPS_IL1RA-Hematopoietic_Myeloid-Granulocytic_cells\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CD177 NBEAL2 CD44 C5AR1 CYP4F11 OLR1	3.48e-06	200	91	6	0b7573ec4e9c67c7d11dd8f5011a70bade30e930
ToppCell	mild_COVID-19_(asymptomatic)-Treg\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	PDE3B CD27 TMEM44 NTN5 SEMA3G	1.21e-05	145	91	5	2d0903009e918500facfd017ff31f2cec1e76131
ToppCell	facs-MAT-Fat-24m-Myeloid-myeloid_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1 OLR1	2.00e-05	161	91	5	65888250b8c1da6a8f9b5376e086a3769a1cbbd8
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TNFSF13 CD177 MYO7A CD27 SEMA3G	2.12e-05	163	91	5	bca9abd02ffb2a90c8386a59f5e25126ae7b6acd
ToppCell	facs-MAT-Fat-24m-Myeloid\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1 OLR1	2.45e-05	168	91	5	6514a27a54ea0f07172b3a73270250143a7b14f0
ToppCell	facs-MAT-Fat-24m-Myeloid-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1 OLR1	2.45e-05	168	91	5	0b6bb335e93476b13955543eeb487243b0067369
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO7A CD44 C5AR1 OLR1 SIGLEC15	2.67e-05	171	91	5	5e93c76ee60f9d0590ebb140812653a5e1369417
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAAF3 TCAF2 ITGA11 C1RL EPDR1	3.24e-05	178	91	5	cb9a446c145b1435cfe12a1d4568aed0924a6a20
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMR3A TMPRSS5 HSD11B2 DMBT1 SMR3B	3.60e-05	182	91	5	2f7d9c0bf7155ac376e63fc9d9542b5c3ab89f04
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A GUSB CD44 C5AR1 OLR1	3.60e-05	182	91	5	94d061b7b5ebbfc564c644bc8b2d52341927145d
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SMR3A TMPRSS5 HSD11B2 DMBT1 SMR3B	3.60e-05	182	91	5	9b556e44ed6aaa50ec572224f5751fb02ce63438
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VIPR1 PDE3B CLEC14A TMEM44 HRH1	4.41e-05	190	91	5	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	VIPR1 PDE3B CLEC14A HRH1 POPDC3	4.41e-05	190	91	5	106ea0bb7b99c697ffc5443d72343df2484250c7
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)\|Adult / Lineage, Cell type, age group and donor	VIPR1 CLEC14A TMEM44 SEMA3G SHROOM2	4.76e-05	193	91	5	39c6c96a2a100b1b290a779d36cc6bc17245720b
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	VIPR1 CLEC14A CD44 HRH1 SEMA3G	5.24e-05	197	91	5	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIPR1 PDE3B TMEM44 SEMA3G SHROOM2	5.24e-05	197	91	5	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	VIPR1 PDE3B CLEC14A TMEM44 SEMA3G	5.37e-05	198	91	5	1d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCell	distal-Hematologic-Interstitial_Macrophage\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	OTOA CD44 C5AR1 OLR1 SIGLEC15	5.37e-05	198	91	5	a35b43d38e18c6f8f0cd9015b8e23f71c729f023
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VIPR1 TCAF2 CLEC14A HRH1 SEMA3G	5.37e-05	198	91	5	5eedcc20e35adbabe268a93b748ee4566b3ffb66
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CD177 CD44 C5AR1 CYP4F11 OLR1	5.50e-05	199	91	5	8c2ab13b5fffbab3da37041a7000d6537fc4db09
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	OTOA TNFSF13 CD44 C5AR1 OLR1	5.50e-05	199	91	5	53dac0455b84597460457ed429969a42ed0fe932
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CD177 CD44 C5AR1 CYP4F11 OLR1	5.63e-05	200	91	5	1592ca96c59eb053d0f0915afb337db9f3a40c91
ToppCell	LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils\|LPS_only / Treatment groups by lineage, cell group, cell type	CD177 NBEAL2 CD44 C5AR1 OLR1	5.63e-05	200	91	5	3504aeba7b30cac9c428ba3871c072e2202752b4
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	OTOA TNFSF13 MYO7A C5AR1 OLR1	5.63e-05	200	91	5	77a68e8fd97a3f3467d25032067fd7ad52ab8522
ToppCell	LPS_only-Hematopoietic_Myeloid-Granulocytic_cells\|LPS_only / Treatment groups by lineage, cell group, cell type	CD177 NBEAL2 CD44 C5AR1 OLR1	5.63e-05	200	91	5	c5afebbc16024c60e84a67be81c78b0bfb73ec68
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-6\|TCGA-Lung / Sample_Type by Project: Shred V9	PAPPA2 SMR3A VWA5B1 SMR3B	1.60e-04	133	91	4	d680c0cf37949aad7bdf04ff5093f005a8c982d6
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PAPPA2 SPTBN5 ISLR2 SLIT1	1.64e-04	134	91	4	6d97fa07f55ae20c17b9d5262e893957cccc6dba
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3_(Neuron.Gad1Gad2.Cplx3)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GHRHR PRSS55 POPDC3	1.74e-04	53	91	3	9c6aba539d540211b2309da1af6a531f3275a49d
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3_(Neuron.Gad1Gad2.Cplx3)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GHRHR PRSS55 POPDC3	1.74e-04	53	91	3	846e031024ad3a4f5c6640b61cf4a0e69dbbcd1c
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD177 CD27 SEMA3G FUT7	1.95e-04	140	91	4	9f105687f5749399fd76043fd85da58be30f2caf
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CD177 CD27 SEMA3G FUT7	1.95e-04	140	91	4	a3be1fb7d2eb44bc123456d03250502938d46d9d
ToppCell	mild_COVID-19_(asymptomatic)-Treg\|World / disease group, cell group and cell class (v2)	CD27 TMEM44 NTN5 SEMA3G	2.23e-04	145	91	4	a3b0e1d0ce0caa8b281a146439d6455db64cc3e5
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nnat_(Neuron.Slc17a7.Syt6-Nnat)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LEFTY2 FUT7 SLC27A5	2.78e-04	62	91	3	dd2e222d454fb78fed8b37901cbf04c0080ed010
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nnat_(Neuron.Slc17a7.Syt6-Nnat)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LEFTY2 FUT7 SLC27A5	2.78e-04	62	91	3	6a3f990e8d59392ad909634a239b3ab4f13d8855
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GDPD5 CLEC14A TMEM44 SEMA3G	3.01e-04	157	91	4	2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5
ToppCell	facs-Lung-Endomucin-24m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBEAL2 C5AR1 PKD1L2 OLR1	3.09e-04	158	91	4	0ed844ab625351a46b74edddf082279ed1bae5c6
ToppCell	facs-Lung-Endomucin-24m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NBEAL2 C5AR1 PKD1L2 OLR1	3.09e-04	158	91	4	b3a810314e253b4fd0f578e759c36fdd21722934
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD44 C1RL C5AR1 OLR1	3.09e-04	158	91	4	6811dc4f101dfa9a9cc13d949760d43aa522bf3b
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CD177 CD27 TMPRSS5 SEMA3G	3.16e-04	159	91	4	ae53ab7a1339007d0b245c6c291ac61e5ff5b682
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CD177 CD27 TMPRSS5 SEMA3G	3.16e-04	159	91	4	b05fda31b77536a1878f55d3199563b53f9420b2
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Crh_(Neuron.Gad1Gad2.Sst-Crh)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DUOX1 TAS1R3 FUT7	3.19e-04	65	91	3	d77193259479d0c1667804682dc5b605ebf7119b
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Crh_(Neuron.Gad1Gad2.Sst-Crh)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DUOX1 TAS1R3 FUT7	3.19e-04	65	91	3	443827bb2c469046026ca9b4c52b22bef0681dff
ToppCell	facs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 PKD1L2 FUT7	3.24e-04	160	91	4	7217730ae14840b935b3bf9aa49becbcbcd8a682
ToppCell	facs-Lung-EPCAM-18m-Hematologic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 PKD1L2 FUT7	3.24e-04	160	91	4	317ef81460c1a31b51119a6309b11be6a8d4ea3e
ToppCell	facs-Lung-EPCAM-18m-Hematologic-leukocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 PKD1L2 FUT7	3.24e-04	160	91	4	e6191240c93da34fc4431a35ef496edf323cb41e
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HPX CD44 HRH1 MAMDC4	3.24e-04	160	91	4	5bec867def73fa8531f8dad611679f4b44f573bd
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD177 CD44 C5AR1 ABCA7	3.31e-04	161	91	4	e227f7b711475624cf80e77f235b1783d88d57b4
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD177 CD44 C5AR1 ABCA7	3.31e-04	161	91	4	8280a029026c272cae9649b27575831b0dd4e242
ToppCell	368C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	REC8 CLEC14A FUT7 CLDN9	3.31e-04	161	91	4	1011094c54381d52566e24c92f89f2efc2aa3eea
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Adora1_(Striatum,_interneuron)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SPTBN5 DUOX1 GPR156	3.34e-04	66	91	3	d6b202d9f5bebaac23b34b689ad306549dec0593
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Adora1_(Striatum,_interneuron)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	SPTBN5 DUOX1 GPR156	3.34e-04	66	91	3	4a714cf035b22da103054098f85f9170c56e9e83
ToppCell	10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4\|Lung / Manually curated celltypes from each tissue	VIPR1 PDE3B CD27 CLDN9	3.39e-04	162	91	4	91cc14aec8d580cf97a1929bc1acb00fcbcdb57a
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD44 C1RL POPDC3 OLR1	3.39e-04	162	91	4	d712bc31840ad1523e3dbf884acbb428a8995001
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	LEFTY2 SLIT1 NTN5 SLC27A5	3.47e-04	163	91	4	218b9ba099cb27aa91c6b73bf89b44895f5dddc3
ToppCell	facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DNAAF3 CD177 PKD1L2 FUT7	3.47e-04	163	91	4	f558ad9569e5137e62a601ba4f073e69ed8f8650
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1	3.55e-04	164	91	4	45a6d809d92fd4eee906da3c812282bacffc9f2f
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1	3.55e-04	164	91	4	aa4358311fc767c292897e3328309d1bcda392d4
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Ptprz1_(Ptprz1)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CD27 HPX SLC27A5	3.65e-04	68	91	3	9ce22a6dea3c17d5352572ea0dabe6c6120b9f82
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Ptprz1_(Ptprz1)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CD27 HPX SLC27A5	3.65e-04	68	91	3	89d337147899a978a7467db24e876a613bdd2288
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	REC8 VIPR2 GPR156 CYP4F11	3.72e-04	166	91	4	4d63c758d46e73311b864148c646bf081498dee7
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|368C / Donor, Lineage, Cell class and subclass (all cells)	REC8 VIPR2 GPR156 CYP4F11	3.72e-04	166	91	4	4160ccf9291072a6e2782f9ad141bc9a9747f3ad
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNFSF13 MYO7A CD44 C5AR1	3.72e-04	166	91	4	c948df4279ff55b0d2739ad08b145c96ef2dbc97
ToppCell	facs-GAT-Fat-24m-Myeloid-myeloid_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1	3.81e-04	167	91	4	5d9ffbcb539d9c50cef9dd792ea11aa37dd2c1df
ToppCell	facs-GAT-Fat-24m-Myeloid\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1	3.81e-04	167	91	4	c31e41fb76ba261ac546fac3cc2b8337e39bfa86
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE3B GPATCH3 CD27 FUT7	3.81e-04	167	91	4	4b6853efefea5178280ba7c31facda0fbd1cc469
ToppCell	droplet-Spleen-nan-21m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD177 C1RL C5AR1 OLR1	3.81e-04	167	91	4	cfcd72292c733cdb18c92fdb61b68f6806d22c8c
ToppCell	facs-GAT-Fat-24m-Myeloid-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1	3.81e-04	167	91	4	a04d1f2413fd24ad5e9cc67312220606157fecf3
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	TNFSF13 CD177 CD27 SEMA3G	3.89e-04	168	91	4	63437b3c3a66f953eaed600965ab193f9cc49da2
ToppCell	droplet-Heart-nan-18m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAOK2 CD177 NBEAL2 TARS2	3.89e-04	168	91	4	2201ae834b53cbdc085f8f02607fa5b5bd911268
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD177 C1RL C5AR1 OLR1	3.89e-04	168	91	4	c0ff30e2c47005514131a0866cf10a1c228128fc
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-plasma_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD44 HAPLN4 TMEM214 PCK2	3.89e-04	168	91	4	bc7d5f0e5d222922eaf1c8e8c87aab189209d6b6
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B0\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	VIPR2 CD27 CD44 IGKV1D-8	3.98e-04	169	91	4	89b5452e0d8d058648a1d2659f1611fd6aebc6b6
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	DNAAF3 VIPR2 COL20A1 SCNN1D	3.98e-04	169	91	4	29db25e7c5f31d98a08a35d7ec5ade203242bc50
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	DNAAF3 VIPR2 COL20A1 SCNN1D	3.98e-04	169	91	4	b1611e61f635f8f9b87250e026ad30999cbee041
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GHRHR VIPR1 PDE3B CD27	3.98e-04	169	91	4	a388e53deac861a185c31e9cceddae7bcb344700
ToppCell	facs-SCAT-Fat-24m-Myeloid-myeloid_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1	4.07e-04	170	91	4	13480e5f2de50425e42be0144b876e9aa4006a68
ToppCell	facs-SCAT-Fat-24m-Myeloid-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1	4.07e-04	170	91	4	d22cd09a43a14045bb1181189fe8accf78fdde3b
ToppCell	facs-SCAT-Fat-24m-Myeloid\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 CD44 C5AR1	4.07e-04	170	91	4	f9968d3735328a39157764343dd40f1ad8bf710d
ToppCell	droplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 HRH1 C5AR1 TRRAP	4.16e-04	171	91	4	7ca404539344e14dcd90c746c9122f713a7db78b
ToppCell	droplet-Lung-nan-18m-Myeloid-lung_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 HRH1 C5AR1 TRRAP	4.16e-04	171	91	4	ab113c8e773b0af47a87aed50e96be3ba71c3c82
ToppCell	metastatic_Lymph_Node-Myeloid_cells-pDCs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	VIPR2 ADAMTS4 SLIT1 FUT7	4.16e-04	171	91	4	1f8e66073088fc1969782e443bf00f8c1877ea91
ToppCell	facs-BAT-Fat-3m-Myeloid-nan\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD177 GUSB C1RL	4.25e-04	172	91	4	5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDPD5 VIPR2 C1RL DMBT1	4.35e-04	173	91	4	c62e3ffed55bbb00dcaef6da0aab8446f3f55085
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDPD5 VIPR2 C1RL DMBT1	4.35e-04	173	91	4	f612d4ea9ab8dcde475f4118bca3e49be786e7fa
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TAS1R3 CD44 HRH1 EPDR1	4.35e-04	173	91	4	c63a615998d13b1725b5767f4ad2ec7e2b61db68
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDPD5 VIPR2 DMBT1 PKD1L2	4.44e-04	174	91	4	165e14cad57e90aa247dcecfaa3c2e8ff2a470ad
ToppCell	10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages\|bone_marrow / Manually curated celltypes from each tissue	SPTBN5 OTOA HRH1 C5AR1	4.44e-04	174	91	4	0746344d62aa7ab77c378e9d5a9f9238e741a76b
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-E\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	VIPR1 PDE3B CLEC14A SEMA3G	4.44e-04	174	91	4	4a1b67ce5ea353b3f81f59fa57da07668146afca
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GDPD5 VIPR2 DMBT1 PKD1L2	4.44e-04	174	91	4	4289dfc7613db4bb3d706b9b65d06e84c0c53558
ToppCell	Healthy-Plasmablast\|World / disease group, cell group and cell class	LEFTY2 GPR25 CD27 IGKV1D-8	4.44e-04	174	91	4	6becb456d8f44a1224c6d42be78d4c8cdb51f199
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR25 CLEC14A SLIT1 FUT7	4.44e-04	174	91	4	6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d
ToppCell	(03)_Secretory-(0)_uninjured\|(03)_Secretory / shred by cell type and Timepoint	PDE3B C1RL DMBT1 EPDR1	4.44e-04	174	91	4	ebdddb5091afcc49ab533c890f260f709880c5f9
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF13 CD44 HRH1 DMBT1	4.54e-04	175	91	4	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A FKTN SLIT1 SEMA3G	4.64e-04	176	91	4	3766e0533b103ec92ac75eba3df02e287efc53fa
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO7A CD44 C5AR1 OLR1	4.64e-04	176	91	4	6548797336c9f4ca0f38e74a2c629e2a4defa252
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A FKTN SLIT1 SEMA3G	4.64e-04	176	91	4	aa1bada2175d8370fc71939a607407155259d195
Drug	Btzo-tdmap	VIPR1 VIPR2 C5AR1	4.93e-06	9	90	3	CID000124335
Drug	mono-(2-ethylhexyl)phthalate	SPTBN5 OTOA ADAMTS4 MYO7A NBEAL2 SLIT1 EBP SLC5A9 POPDC3 HSD11B2 EPDR1 ABCA7	1.07e-05	658	90	12	ctd:C016599
Drug	Rp-8-CPT-cAMPS	VIPR1 VIPR2 PDE3B PCK2	1.09e-05	35	90	4	CID010413188
Drug	Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A	GDPD5 GPATCH3 MYO7A SMPD2 DMBT1 ABCA7 CTSO	1.33e-05	197	90	7	5463_UP
Drug	Metolazone [17560-51-9]; Up 200; 11uM; MCF7; HT_HG-U133A	TAOK2 POMT2 VIPR1 GDPD5 NBEAL2 SMPD2 MAPK8IP3	1.33e-05	197	90	7	1514_UP
Drug	Griseofulvin [126-07-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A	VIPR1 DUOX1 SMR3A POPDC3 C5AR1 DMBT1 CYP4F11	1.37e-05	198	90	7	2293_UP
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	TAOK2 REC8 LMF2 HPX HRH1 POPDC3 SMR3B	1.47e-05	200	90	7	5626_UP
Drug	AC1L9L52	VIPR1 VIPR2	1.55e-05	2	90	2	CID000447705
Disease	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1	POMT2 FKTN POMT1	2.06e-07	5	82	3	cv:C4284790
Disease	Walker-Warburg syndrome (is_implicated_in)	POMT2 FKTN POMT1	2.06e-07	5	82	3	DOID:0050560 (is_implicated_in)
Disease	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1	POMT2 FKTN POMT1	2.06e-07	5	82	3	236670
Disease	Qualitative or quantitative defects of alpha-dystroglycan	POMT2 FKTN POMT1	4.11e-07	6	82	3	cv:C2936406
Disease	Congenital muscular dystrophy	POMT2 FKTN POMT1	4.47e-06	12	82	3	cv:C0699743
Disease	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	POMT2 FKTN POMT1	7.36e-06	14	82	3	C1836373
Disease	alpha-Dystroglycanopathies	POMT2 FKTN POMT1	7.36e-06	14	82	3	C2936406
Disease	Muscle eye brain disease	POMT2 FKTN POMT1	7.36e-06	14	82	3	C0457133
Disease	Fukuyama Type Congenital Muscular Dystrophy	POMT2 FKTN POMT1	7.36e-06	14	82	3	C0410174
Disease	Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1	POMT2 FKTN POMT1	7.36e-06	14	82	3	C4284790
Disease	Walker-Warburg congenital muscular dystrophy	POMT2 FKTN POMT1	9.19e-06	15	82	3	C0265221
Disease	muscular dystrophy (is_implicated_in)	POMT2 FKTN POMT1	1.37e-05	17	82	3	DOID:9884 (is_implicated_in)
Disease	Cobblestone Lissencephaly	POMT2 POMT1	2.28e-05	3	82	2	C0431376
Disease	lissencephaly (is_implicated_in)	POMT2 POMT1	7.59e-05	5	82	2	DOID:0050453 (is_implicated_in)
Disease	autosomal recessive limb-girdle muscular dystrophy (is_implicated_in)	POMT2 POPDC3	7.59e-05	5	82	2	DOID:0110274 (is_implicated_in)
Disease	Muscular Dystrophies, Limb-Girdle	POMT2 FKTN POMT1	9.68e-05	32	82	3	C0686353
Disease	Walker-Warburg syndrome (implicated_via_orthology)	POMT2 POMT1	1.59e-04	7	82	2	DOID:0050560 (implicated_via_orthology)
Disease	muscular dystrophy-dystroglycanopathy type B1 (implicated_via_orthology)	FKTN POMT1	2.11e-04	8	82	2	DOID:0050588 (implicated_via_orthology)
Disease	blood tin measurement	DNAAF3 SLIT1	2.20e-03	25	82	2	EFO_0021530
Disease	psychosis predisposition measurement	CD44 VWA5B1	2.37e-03	26	82	2	EFO_0008337
Disease	IGF-1 measurement	PAPPA2 GHRHR ITGA11 TNFSF13 SLIT1 MAPK8IP3	2.41e-03	488	82	6	EFO_0004627

Protein segments in the cluster

Peptide	Gene	Start	Entry
PLFGLWGCTRTLFWS	LINC00311	96	Q8N616
LVLFLAGSSGWAWVP	MAMDC4	11	Q6UXC1
LPSGWLGCCTLGIPW	ERVPABLB-1	281	P60509
AWLLGGLWAWTLCGL	EPDR1	16	Q9UM22
GLWAWTLCGLCSLGA	EPDR1	21	Q9UM22
PWWLCVLGTLVGLSA	CD27	6	P26842
TLPLWAAAAALGGRW	GPR25	91	O00155
GLALAPALWWGVVCP	CD177	421	Q8N6Q3
GLAWIACAVAWGLAL	C5AR1	151	P21730
WPSGGAWLLVAARAL	HSD11B2	6	P80365
LWLGWFLSCLGPFLL	ABCA7	591	Q8IZY2
ALWLVWALLGVAGSC	ISLR2	6	Q6UXK2
GWLPPELLGLWTHCA	REC8	356	O95072
ALAWTLLVGAWTPLG	DUOX1	6	Q9NRD9
GALQSWGLWLGCPLL	OTOA	1131	Q7RTW8
KLWCAAGVNLSGWRP	MAPK8IP3	706	Q9UPT6
WSLGCVIAELFLGWP	HIPK1	376	Q86Z02
GLLLLWLPGARCAIW	IGKV1D-8	11	A0A087WSZ0
WLDSHGTWLPGRCLI	GPATCH3	126	Q96I76
LNWHGLSPLGWPSCR	PCK2	11	Q16822
ICWLIVAAAWLGGSI	OR2T7	131	P0C7T2
GRSCGSWWLLALPAC	PDE3B	146	Q13370
ALWLLWLLGSAPRGT	FUT7	26	Q11130
VNAPWLFSLLWCAGV	GDPD5	456	Q8WTR4
GLVVAWALSLWPGFT	ITGA11	6	Q9UKX5
CWLIVAAAWLGGSID	OR2T27	141	Q8NH04
LGLPWWGAIAACTVF	OXA1L	136	Q15070
YSPWWCLAAATLGVL	OLR1	31	P78380
WVLSFCIAGPSLTGW	GPR45	156	Q9Y5Y3
GLPWWCILVGWLLVA	PKD1L2	1816	Q7Z442
GWWLCERQLPSGGLN	RABGGTB	216	P53611
LLWTPSVGLVLWAGA	SMPD2	356	O60906
DAWLRWVLAGALCAG	POMT1	631	Q9Y6A1
GLSPWLTCLEDGLWS	PAPPA2	1501	Q9BXP8
ALLLCGLVALLGWSW	CYP2U1	36	Q7Z449
GLAGRWLWGAQPCLL	ADAMTS4	11	O75173
LLSTAFPVCIWSLGW	HTT	1031	P42858
AGAWLTALGFSLPWE	GPR135	231	Q8IZ08
FGSVSWWGLSPALDL	DNAAF3	11	Q8N9W5
WHAAWGLCLVPLSLA	CD44	6	P16070
PAHLGLCLWLWLGAT	COL20A1	6	Q9P218
LCLWLWLGATLGREQ	COL20A1	11	Q9P218
AVAWAALGPLLWGCA	GUSB	6	P08236
LSWLGLGPVAASPWL	CYP4F11	6	Q9HBI6
ASPWLLLLLVGGSWL	CYP4F11	16	Q9HBI6
CLRWGLSRAGVWLLP	MRPL58	6	Q14197
WLLLWGVLQACPTRG	C1RL	26	Q9NZP8
LGVPFWLSSGTCLGW	FKTN	291	O75072
TTLGCPATWDGLLCW	GHRHR	51	Q02643
LCWALWVLPLAGPGA	LEFTY2	6	O00292
WGHCAPSPLLLWTLL	GLMP	11	Q8WWB7
SDVWIALIWGCKGLL	GPR156	221	Q8NFN8
GALWAAAWGVLLLTA	HAPLN4	11	Q86UW8
SKWSLGRPLCLFWLS	HRH1	91	P35367
ACLWGPLSLWVVIAF	EBP	126	Q15125
CLLWGQVLSTGGWIP	DMBT1	11	Q9UGM3
LGVNLIACLAWWIGG	SCAMP4	51	Q969E2
SWGLLSLGALVALCW	SCNN1D	251	P51172
LLGLGFLCSAVWAWV	POPDC3	56	Q9HBV1
LFCWSGGWGLPSVDL	MTX1	156	Q13505
GAPVALGLWSLCWSL	HPX	6	P02790
LGLWSLCWSLAIATP	HPX	11	P02790
LGVLAESCGGKWPLW	TARS2	596	Q9BW92
WLLACLAWVLPTGSF	SIGLEC15	6	Q6ZMC9
RLCAWGLASWPLARG	POMT2	686	Q9UKY4
GKGAPLCDWNVWTAL	TCAF2	816	A6NFQ2
KLTSRCPAWWGLTAL	LMF2	186	Q9BU23
ILSAAWASGGPWRLL	NTN5	91	Q8WTR8
LHWGALWRQLASPCG	NBEAL2	1801	Q6ZNJ1
WILGLWALAACFTPG	SMR3B	6	P02814
WAGCWPSDTALGALE	SHROOM2	491	Q13796
PGLIFGLTVLATWCW	SLC5A9	281	Q2M3M2
LLWSWFCGLSGTPEQ	SLC5A9	621	Q2M3M2
GAAWLLAWPGLALPL	TAOK2	1046	Q9UL54
LASWLAGFLWVLCPT	OR6T1	146	Q8NGN1
LGLAELSQCWAGLEW	SPTBN5	391	Q9NRC6
WLLWLLCRGGGDADS	CTSO	11	P43234
LGWLGTLVSCALPLW	CLDN9	16	O95484
ALCLLWQALWPGPGG	CLEC14A	6	Q86T13
WLCVLAGALAWALGP	VIPR1	11	P32241
LSWADRLSGCLRGPW	TAS1R3	666	Q7RTX0
RLSGCLRGPWAWLVV	TAS1R3	671	Q7RTX0
WLGLAKLGCPTAWIN	SLC27A5	191	Q9Y2P5
WILGLWALAACFTPG	SMR3A	6	Q99954
SWLGETLPLWGSHLL	TMEM214	541	Q6NUQ4
WLLVCHEGWSPALGL	TMPRSS5	131	Q9H3S3
LPLSLGPCWALWVAV	TMEM44	141	Q2T9K0
KVCLSILGTWTGPAW	UBE2Z	186	Q9H832
PFCGGSILNKWWILT	PRSS55	91	Q6UWB4
LIGWGLPTVCIGAWT	VIPR2	246	P41587
GWRPWLFLSLECVSL	TMEM187	136	Q14656
MAPSAWAICWLLGGL	SEMA3G	1	Q9NS98
LLWAAAWRLGASACP	SLIT1	21	O75093
WLAWIPQLLTCLVGS	TRRAP	3231	Q9Y4A5
ALSVALWLSWGAALG	TNFSF13	26	O75888
LWLSWGAALGAVACA	TNFSF13	31	O75888
AWAPGSWNKLCLATL	VWA5B1	196	Q5TIE3
WPGQWRALCSLAIEG	NLRP13	476	Q86W25
ERGWELLWLCTGLFP	MYO7A	1831	Q13402